CN Patent

CN104230866A — C-芳基葡糖苷sglt2抑制剂和方法

Assigned to Bristol Myers Squibb Co · Expires 2014-12-24 · 11y expired

What this patent protects

本发明提供了抑制SGLT2的化合物，其具有式(1)的化学结构。本发明还提供了单独应用SGLT2抑制量的上述化合物或联合应用SGLT2抑制量的上述化合物和其它抗糖尿病试剂或其它治疗试剂来治疗糖尿病和相关疾病的方法。

USPTO Abstract

本发明提供了抑制SGLT2的化合物，其具有式(1)的化学结构。本发明还提供了单独应用SGLT2抑制量的上述化合物或联合应用SGLT2抑制量的上述化合物和其它抗糖尿病试剂或其它治疗试剂来治疗糖尿病和相关疾病的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN104230866A
Jurisdiction
CN
Classification
—
Expires
2014-12-24
Drug substance claim
No
Drug product claim
No
Assignee
Bristol Myers Squibb Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.